AMAG Pharmaceuticals (AMAG) Post Smaller Q3 Loss, Sees Higher FY Revs
Tweet Send to a Friend
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) reported Q3 EPS of ($0.01), $0.11 better than the analyst estimate of ($0.12). Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
